Ategrity Specialty grants 125K options to exec

ASIC’s President and Chief Underwriting Officer received two long-dated stock option grants with staged vesting schedules.

Rhea-AI Filing Summary

Ategrity Specialty Insurance Co Holdings (ASIC) reported that President and Chief Underwriting Officer Chris Schenk received two grants of stock options on September 4, 2026. Each grant covers 62,829 options for common stock with an exercise price of $27.40 per share and an expiration date of September 4, 2036.

One option grant vests in five equal annual installments beginning on September 4, 2027, and the other vests in five equal annual installments beginning on September 4, 2028. No Rule 10b5-1 trading plan is reported for these awards.

Insider Trade Summary

Grant/Award: 125,658 shares

Grant/Award 2 txns

Insider Schenk Chris

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	62,829	$0.00	$0.00
Grant/Award	Stock Option F2	62,829	$0.00	$0.00

Holdings After Transaction: Stock Option — 125,658 contracts (Direct)

Footnotes (2)

1. F1. The option vests in five equal annual installments beginning on September 4, 2028.
2. F2. The option vests in five equal annual installments beginning on September 4, 2027.

Key Figures

Options granted (first grant): 62,829 options Options granted (second grant): 62,829 options Total options granted: 125,658 options +4 more

7 metrics

Options granted (first grant) 62,829 options Grant of stock options to Chris Schenk on September 4, 2026

Options granted (second grant) 62,829 options Second grant of stock options to Chris Schenk on September 4, 2026

Total options granted 125,658 options Combined total of both option grants reported for September 4, 2026

Exercise price $27.40 per share Exercise price for each stock option grant

Expiration date September 4, 2036 Expiration date for both stock option grants

Vesting start (first grant) September 4, 2027 First grant vests in five equal annual installments beginning on this date

Vesting start (second grant) September 4, 2028 Second grant vests in five equal annual installments beginning on this date

Key Terms

stock option, exercise price, vesting, expiration date, +1 more

5 terms

stock option financial

"reported that President and Chief Underwriting Officer Chris Schenk received two grants of stock options"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"Each grant covers 62,829 options for common stock with an exercise price of $27.40 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"One option grant vests in five equal annual installments beginning on September 4, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"an exercise price of $27.40 per share and an expiration date of September 4, 2036"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these awards"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ASIC insider Chris Schenk report on this Form 4 filing?

Chris Schenk, President and Chief Underwriting Officer of Ategrity Specialty Insurance Co Holdings (ASIC), reported receiving two grants of stock options for common stock on September 4, 2026, as part of his equity compensation.

How many ASIC stock options were granted to Chris Schenk?

Chris Schenk received two separate grants of 62,829 stock options each, for a total of 125,658 options, all relating to ASIC common stock.

What is the exercise price and expiration date of the ASIC options granted?

Each of Chris Schenk’s option grants has an exercise price of $27.40 per share and an expiration date of September 4, 2036, providing a long-dated opportunity to purchase ASIC common stock.

What are the vesting schedules for the ASIC options granted to Chris Schenk?

One grant of 62,829 options vests in five equal annual installments beginning on September 4, 2027. The other grant of 62,829 options vests in five equal annual installments beginning on September 4, 2028.

Were the ASIC option grants to Chris Schenk made under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these stock option grants to Chris Schenk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 04:15 PM EDT Accepted by SEC EDGAR 09/09/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schenk Chris

(Last) (First) (Middle)

9 WEST 57TH STREET

33RD FLOOR

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ategrity Specialty Insurance Co Holdings [ ASIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$27.4	09/04/2026		A		62,829		(1)	09/04/2036	Common Stock	62,829	$0	62,829	D
Stock Option	$27.4	09/04/2026		A		62,829		(2)	09/04/2036	Common Stock	62,829	$0	62,829	D

Explanation of Responses:

1. The option vests in five equal annual installments beginning on September 4, 2028.

2. The option vests in five equal annual installments beginning on September 4, 2027.

Remarks:

President and Chief Underwriting Officer.

	/s/ Eric Crespolini, Attorney-in-Fact	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)